Neuropace, Inc. NPCE Deferred Tax Assets, Gross
Deferred Tax Assets, Gross at other companies
Other financials
Where this comes from
Reported directly by Neuropace, Inc. in its filing.
Tagged under the XBRL concept us-gaap:DeferredTaxAssetsGross.
The official record: Neuropace, Inc.’s 10-K, filed March 3, 2026, on SEC EDGAR. View the filing →
Ask your AI about Neuropace, Inc.'s deferred tax assets, gross.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Neuropace, Inc.'s deferred tax assets, gross?
- Neuropace, Inc. (NPCE) reported deferred tax assets, gross of $88.37M in Q4 2025.
- How has Neuropace, Inc.'s deferred tax assets, gross changed year-over-year?
- Neuropace, Inc.'s deferred tax assets, gross increased by 8.8% year-over-year, from $81.2M to $88.37M.
- What is the long-term trend for Neuropace, Inc.'s deferred tax assets, gross?
- Over 5 years (2020 to 2025), Neuropace, Inc.'s deferred tax assets, gross has grown at a 14.9% compound annual growth rate (CAGR), from $44.22M to $88.37M.